Episodes 16-30 of 42
Exploring Early Usage of a 2L ITP Treatment Option: Clinical Profile and Access Resources
Medical Industry FeatureExploring Early Usage of a 2L ITP Treatment Option: Clinical Profile and Access Resources
Investigating HLH: Our Current Understanding of a Rare Disease
Medical Industry FeatureInvestigating HLH: Our Current Understanding of a Rare Disease
Advanced Endometrial Carcinoma: A Look Into Care Considerations
Medical Industry FeatureAdvanced Endometrial Carcinoma: A Look Into Care Considerations
Addressing Treatment Gaps Among Patients with MDS-Associated Anemia
Medical Industry FeatureAddressing Treatment Gaps Among Patients with MDS-Associated Anemia
Cholangiocarcinoma: Treatment with Targeted Therapies
Medical Industry FeatureCholangiocarcinoma: Treatment with Targeted Therapies
Advancements in Pretreated HR+/HER2- Metastatic Breast Cancer
Medical Industry FeatureAdvancements in Pretreated HR+/HER2- Metastatic Breast Cancer
Advancements in Pretreated Metastatic Triple-Negative Breast Cancer
Medical Industry FeatureAdvancements in Pretreated Metastatic Triple-Negative Breast Cancer
Navigating Treatment Goals With a CDK4/6 Inhibitor in HR+/HER2- Metastatic Breast Cancer: Addressing Barriers
Medical Industry FeatureNavigating Treatment Goals With a CDK4/6 Inhibitor in HR+/HER2- Metastatic Breast Cancer: Addressing Barriers
Advances in HR-MDS: Updates in Diagnosis, Risk Assessment, and Current Standard of Care Challenges
Medical Industry FeatureAdvances in HR-MDS: Updates in Diagnosis, Risk Assessment, and Current Standard of Care Challenges
Navigating Treatment Goals With a CDK4/6 Inhibitor in HR+/HER2- mBC
Medical Industry FeatureNavigating Treatment Goals With a CDK4/6 Inhibitor in HR+/HER2- mBC
Updates in CLL Treatment: 5-Year Off Treatment Analyses of the CLL14 and MURANO Trials
Medical Industry FeatureUpdates in CLL Treatment: 5-Year Off Treatment Analyses of the CLL14 and MURANO Trials
Advances in BPDCN Treatment: Targeting Its Pathophysiology
Medical Industry FeatureAdvances in BPDCN Treatment: Targeting Its Pathophysiology
Managing BPDCN as a Targeted Treatment Option
Medical Industry FeatureManaging BPDCN as a Targeted Treatment Option
An Approach to Treating BPDCN Patients with Prior or Concomitant Hematologic Malignancies
Medical Industry FeatureAn Approach to Treating BPDCN Patients with Prior or Concomitant Hematologic Malignancies
Treating Metastatic Pancreatic Cancer: An Expert Recap of the POLO Trial Design & Results
Medical Industry FeatureTreating Metastatic Pancreatic Cancer: An Expert Recap of the POLO Trial Design & Results
